BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

ALS (amyotrophic lateral sclerosis) clinical trials and catalysts

Active industry-sponsored trials on ClinicalTrials.gov for amyotrophic lateral sclerosis: 82 (64 sponsors; 10 newly posted in the last 180 days, 5 stopped in the last 180 days; 6 new-entrant sponsors). Momentum score 12.2, rank 56 of 91 on the disease-area ranking. As of 2026-11-18.

Phase distribution: Early Phase 1 2, Phase 1 21, Phase 2 22, Phase 3 12, Phase 4 1, N/A 24.

Most active sponsors, by phase

SponsorActive trialsBy phaseNew (window)Upcoming readouts
AB Science2P3 200
Biogen BIIB4NA 1, P3 1, P2 1, P4 110
Brainstorm-Cell Therapeutics BCLI1P3 100
Coya Therapeutics COYA1P3 101
Gipfel Life Sciences GmbH1P3 100
Ionis Pharmaceuticals, Inc. IONS1P3 100
MediciNova MNOV1P3 101
Prilenia1P3 100
Rapa Therapeutics LLC1P3 100
Shanghai Zhimeng Biopharma, Inc.1P3 100
Spinogenix1P3 100
Neuralink Corp7NA 710
Eli Lilly and Company LLY4P1 410
Cognixion3NA 310
Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.2P1 1, P2 100
RJK Biopharma Ltd2P1 1, EARLY_P1 101
Synchron, Inc.2NA 201
1ST Biotherapeutics, Inc.1P1 100
AC Immune SA ACIU1EARLY_P1 100
Ambulanzpartner Soziotechnologie APST GmbH new entrant1NA 110
Amylyx Pharmaceuticals Inc. AMLX1P1 101
Ashvattha Therapeutics, Inc.1P2 100
Biocells Medical1NA 100
Brain Trust Bio1P1 100
Cellenkos, Inc.1P1 101

New-entrant sponsors: Ambulanzpartner Soziotechnologie APST GmbH.

Recently stopped trials

Upcoming trial readouts (next 90 days)

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2026-12-15 est.P1/P2PLL TX AUSTRALIA PTY LTDNCT06513546 A Study to Evaluate the Safety, Efficacy, and Pharmacodynamics of PLL001 in ALS PatientsAmyotrophic Lateral Sclerosis; ALSnot yet recruiting153
2027-01 est.P1/P2Inflammasome TherapeuticsNCT07396818 Kamlanoflast In Amyotrophic Lateral SclerosisALS (Amyotrophic Lateral Sclerosis); ALS; Neuro-Degenerative Disease; Neuro-Degenerative Diseases; Mnot yet recruiting40

Readouts in the last 180 days

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2026-10 est.P2Corcept Therapeutics CORTNCT05407324 Dazucorilant in Patients With Amyotrophic Lateral SclerosisAmyotrophic Lateral Sclerosisactive not recruiting279
2026-08-12P2argenx ARGXNCT06441682 A Safety and Efficacy Study of ARGX-119 in Adult Patients With Amyotrophic Lateral Sclerosis (ALS)Amyotrophic Lateral Sclerosisterminated60
2026-07 est.P2Woolsey PharmaceuticalsNCT05218668 Rho Kinase Inhibitor in Amyotrophic Lateral Sclerosis (REAL)Amyotrophic Lateral Sclerosisactive not recruiting40
2026-06-23P2Novartis Pharmaceuticals NVSNCT06643481 A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS)Amyotrophic Lateral Sclerosis (ALS)active not recruiting251
2026-06-17P3Ionis Pharmaceuticals, Inc. IONSNCT04768972 FUSION: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ION363 in Amyotrophic Lateral Sclerosis Participants With Fused in SaAmyotrophic Lateral Sclerosisactive not recruiting89
2026-06 est.P2Clene Nanomedicine CLNNNCT05299658 An Open-Label Extension for the Phase 2 Study in Early Symptomatic Amyotrophic Lateral Sclerosis Patients on Stable Background Therapy to Assess Bioenergetic CaAmyotrophic Lateral Sclerosisactive not recruiting40

Landscape counts: ClinicalTrials.gov, industry lead sponsors, active statuses, via the free hosted BioCatalystFeed MCP tool condition_landscape (query "amyotrophic lateral sclerosis"); readouts matched by condition text. Registry counts only; not a forecast.

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.